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Daylight photodynamic therapy (dPDT) is a widely used treatment in the management of field-change 
actinic keratoses (AK).1 Daylight PDT relies on natural daylight activating photosensitisers (typically 
protoporphyrin-IX, PpIX) in diseased tissue to initiate PDT effects. During the delivery of dPDT, it is 
recommended that a minimum PpIX-effective light dose is delivered to the treatment site.2 PpIX-effective 
light dose is the product of the spectral irradiance of the light source and the normalised PpIX absorption 
spectrum, integrated over the treatment duration. The current European guidelines suggest a minimum 
PpIX-effective dose of 8 J cm-2, though other research suggests that this may be lower.3–5 Daylight PDT 
may be undertaken using daylight through window glass in situations where there is ample daylight, but the 
outdoor conditions are unfavourable. 
Standard practice in dPDT involves application of a high SPF sunscreen on all exposed sites prior to pro-
drug application and subsequent sun exposure. It is recommended that organic (chemical) sunscreens are 
used, which filter only the ultraviolet (UV) part of the spectrum.1 However, the absorption spectrum of 
PpIX extends into the UVA (<400 nm), and therefore some sunscreens may attenuate light that might 
otherwise activate PpIX. This means that in published literature the reported dose may be higher than the 
actual dose delivered to the skin, depending upon the sunscreen used. 
We would like to initiate discussion, considering the following. A spectral irradiance measurement is taken 
in clear skies (13:00 GMT 14/05/14, Chilton, UK). This measurement is weighted for PpIX absorption, 
and then weighted for either the transmission spectra of double-glazed window glass or one of several 
commercial sunscreens (Figure 1, sunscreen transmission measured with Labsphere UV1000 (Labsphere, 
New Hampshire), 2 mg cm-2 density on Transpore tape and quartz slide).6 The resultant PpIX-weighted 
dose values are compared for a 2 or 2.5-hour treatment duration in dPDT and conservatory-based dPDT 
respectively. 
The reduction in PpIX-weighted dose through different sunscreens varied, between a 38% and 92% 
reduction, while through window glass the PpIX dose was reduced by 22%. All sunscreens measured have 
some visible light attenuation (>400 nm), and critically at the 408 nm absorption peak of PpIX.7 One of 
the first published studies on dPDT compared the PpIX and P20 SPF20 (Riemann A/S, Denmark) 
absorption spectra, which at the time had a formulation with significant UVA transmission.2 However, the 
formulation has updated in the intervening years to attenuate more UVA resulting in a theoretically lower 
PpIX dose. Additionally, Actinica® (Galderma, Switzerland), one of the most commonly used sunscreens 
in dPDT, absorbed heavily in the UVA and reduced the PpIX dose to 35% of the unfiltered dose. This 
may explain, in part, our own experience with dPDT, which has tended to show lower efficacy rates than 
those in published studies following single dPDT treatments.8 UVA and visible light attenuation by 
sunscreens may in part explain this difference, with particular relevance at more northerly latitudes with 
less daylight and thus more likely to deliver below the minimum dose threshold. 
A reduction in dose is also seen for conservatory-based dPDT, which is accounted for with longer 
recommended treatment times, but there remains a lower reduction in dose compared with sunscreens. 
Our results highlight the large differences in PpIX-effective dose depending on the sunscreen used and, 
therefore, careful consideration of the choice of sunscreen is important. Ideally the spectral transmission 
of the sunscreen should be known; our results show that simply relying on organic sunscreens may not be 
adequate (from Figure 1, 5 of 9 sunscreens contain only organic filters). In our clinic, sunscreen is applied 
by trained nurses, however with variation in application and considering self-administered dPDT, higher 
doses to the skin may result than presented here. Previous published literature has not always considered 
the absorption of different sunscreens and their impact on PpIX-effective dose and therefore it may be 
that simple comparisons between studies are not always applicable. Daylight PDT is still an effective 
treatment however, perhaps due to centres typically performing dPDT in favourable weather conditions, 
therefore avoiding the minimum dose by delivering high doses of light. 
Daylight PDT continues to evolve, and with more diverse methodology comes a need for more detailed 
understanding of dosimetry. It is important that the dosimetry underlying effective dPDT is detailed in 
order to provide confidence to practitioners that effective doses are delivered. Awareness that both 
sunscreen choice and use, and window glass reduce the effective dose of light delivery by a variable, yet 
significant amount is helpful in determining dose regimes to compensate and avoid potential loss of efficacy. 
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Figure 1. a) Sunscreen and window glass spectral transmission data. Sunscreen transmission data only available up to 
450 nm, transmission above 450 nm assumed to be spectrally flat. Sunscreens categorised by labelled SPF rating, and 
whether they contain organic (O) and/or inorganic (I) filters. b) PpIX dose (± standard deviation) is calculated for 
each sunscreen transmission (mean for five transmission measurements on each sample) and through window glass 
for a representative daylight spectrum (350-800 nm) and treatment duration, and the resultant percentage reduction 
in dose is displayed. 
 
